The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
Proteolytic processing of Alzheimer’s β‐amyloid precursor protein
Open accessAbstract
J. Neurochem. (2012) 120 (Suppl. 1), 9–21. β‐Amyloid precursor protein (APP) is a critical factor in the pathogenesis of Alzheimer’s disease (AD). APP undergoes post‐translational proteolysis/processing to generate the hydrophobic β‐amyloid (Aβ) peptides. Deposition of Aβ in the brain, forming oligomeric Aβ and plaques, is identified as one of the key pathological hallmarks of AD. The processing of APP to generate Aβ is executed by β‐ and γ‐secretase and is highly regulated. Aβ toxicity can lead to synaptic dysfunction, neuronal cell death, impaired learning/memory and abnormal behaviors in AD models in vitro and in vivo. Aside from Aβ, proteolytic cleavages of APP can also give rise to the APP intracellular domain, reportedly involved in multiple types of cellular events such as gene transcription and apoptotic cell death. In addition to amyloidogenic processing, APP can also be cleaved by α‐secretase to form a soluble or secreted APP ectodomain (sAPP‐α) that has been shown to be mostly neuro‐protective. In this review, we describe the mechanisms involved in APP metabolism and the likely functions of its various proteolytic products to give a better understanding of the patho/physiological functions of APP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–206 of 206
PEN‐2 enhances γ‐cleavage after presenilin heterodimer formation
Shiraishi, H., Sai, X., Wang, H., Maeda, Y., Kurono, Y., Nishimura, M., Yanagisawa, K., & Komano, H. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02597.x · Cited by 25
Xin, H., Stephans, J. C., Duan, X., Harrowe, G., Kim, E., Grieshammer, U., Kingsley, C., & Giese, K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00014-4 · Cited by 21
Reciprocal relationship between APP positioning relative to the membrane and PS1 conformation
Uemura, K., Farner, K. C., Nasser‐Ghodsi, N., Jones, P., & Berezovska, O. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-15 · Cited by 20
Sjölander, A., Zetterberg, H., Andréasson, U., Minthon, L., & Blennow, K. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-37 · Cited by 6
Substrate check of γ-secretase
Zhang, Y., & Xu, H. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0210-140 · Cited by 4
Self-citationMorley (2010) · doi:10.3233/jad-2009-1230
Cited by
New Technologies for Analysis of Extracellular Vesicles
Shao, H., Im, H., Castro, C. M., Breakefield, X., Weissleder, R., & Lee, H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00534 · Cited by 1,675
Alzheimer’s disease: risk factors and potentially protective measures
Silva, M. V. F., Loures, C. D. M. G., Alves, L. C. V., de Souza, L. C., Borges, K. B. G., & Carvalho, M. D. G. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0524-y · Cited by 937
GSK-3β, a pivotal kinase in Alzheimer disease
Llorens-MarÃtin, M., Jurado, J., Hernández, F., & Ãvila, J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00046 · Cited by 451
Endoplasmic Reticulum Stress and Unfolded Protein Response in Neurodegenerative Diseases
Ghemrawi, R., & Khair, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176127 · Cited by 398
Implications of GABAergic Neurotransmission in Alzheimer’s Disease
Li, Y., Sun, H., Chen, Z., Xu, H., Bu, G., & Zheng, H. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00031 · Cited by 277
Self-citation
Metadata
- Authors
- Zhang, H., Ma, Q., Zhang, Y., & Xu, H.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2011-11-28
- Volume
- 120
- Issue
- s1
- Pages
- 9-21
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1504590764
- Cited by
- 343
- References
- 206
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.